Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
RNA (New York, N.Y.)|November 22, 2012
Systematic evaluation of medium-throughput mRNA abundance platformsStephenie D Prokopec, John D Watson, Daryl M Waggott, et al.
Plos One|August 7, 2019
2,3,7,8-Tetrachlorodibenzo-p-dioxin modifies alternative splicing in mouse liverAna B Villaseñor-Altamirano, John D Watson, Stephenie D Prokopec, et al.
Toxicology and Applied Pharmacology|August 2, 2015
Transcriptional profiling of rat white adipose tissue response to 2,3,7,8-tetrachlorodibenzo-ρ-dioxinKathleen E Houlahan, Stephenie D Prokopec, Ren X Sun, et al.
Toxicology and Applied Pharmacology|January 11, 2011
Hepatic transcriptomic responses to TCDD in dioxin-sensitive and dioxin-resistant rats during the onset of toxicityPaul C Boutros, Cindy Q Yao, John D Watson, et al.
Chemico-Biological Interactions|June 25, 2013
Validating reference genes within a mouse model system of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) toxicityStephenie D Prokopec, Nicholas B Buchner, Natalie S Fox, et al.
Rheumatology (Oxford, England)|June 27, 2021
Serological abnormalities that predict progression to systemic autoimmune rheumatic diseases in antinuclear antibody-positive individualsCarolina Muñoz-Grajales, Stephenie D Prokopec, Sindhu R Johnson, et al.
Arthritis Research & Therapy|October 8, 2016
A discrete cluster of urinary biomarkers discriminates between active systemic lupus erythematosus patients with and without glomerulonephritisCarolina Landolt-Marticorena, Stephenie D Prokopec, Stacey Morrison, et al.
Toxicology and Applied Pharmacology|February 21, 2012
Inter-strain heterogeneity in rat hepatic transcriptomic responses to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)Cindy Q Yao, Stephenie D Prokopec, John D Watson, et al.
Rheumatology (Oxford, England)|September 7, 2014
Anti-nucleosome antibodies outperform traditional biomarkers as longitudinal indicators of disease activity in systemic lupus erythematosusTimothy Li, Stephenie D Prokopec, Stacey Morrison, et al.
Kidney International|June 14, 2013
Long-term hemodynamic and molecular effects persist after discontinued renin-angiotensin system blockade in patients with type 1 diabetes mellitusDavid Z I Cherney, Bernard Zinman, Christopher R J Kennedy, et al.
Pageof 4